adthera bio
Stuart Curbishley is a Chief Manufacturing and Development Officer at adthera bio. Prior to this role, Stuart worked at the University of Birmingham for almost two decades as the Head of Business and Project Development for Advanced Therapies. Stuart holds a PhD in Medicine and an MPhil in Immunology and Oncology from the University of Birmingham. Stuart's expertise lies in GMP production of cell therapy products, preparation of ATMP's, design, validation, and management of GMP manufacturing facilities, as well as immune monitoring, T cell assays, DC biology, and leukocyte recruitment.
This person is not in any teams
adthera bio
We are a highly experienced digital first company focused exclusively on cell and gene therapy process development and manufacturing. We are the partner of choice in high quality GxP development and manufacturing in Advanced Therapy Medicinal Products. We take your cell therapy ideas and make them into workable medical interventions for patients, all in a regulatory compliant and quality managed system, to get it right first time. Based on brilliant ideas and curious capable minds, we partner with biotechs and academic centres to bring novel ATMP therapies to market and thus to patients who urgently need them. We have highly personalised approaches from the patient to the client to the treatment outcome.